Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > EBITDA

Arcus Biosciences Inc EBITDA Chart (RCUS)

Arcus Biosciences Inc annual/quarterly EBITDA from 2017 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Arcus Biosciences Inc EBITDA for the quarter ending December 12, 2018 was $-13m a 0.27% decrease of 0m year over year
  • Arcus Biosciences Inc EBITDA for the last 12 months ending December 12, 2018 was $-51m a -10.40% increase of 5m year over year
  • Arcus Biosciences Inc Annual EBITDA for 2018 was $-51m a 0.71% decrease of 0m from 2017
  • Arcus Biosciences Inc Annual EBITDA for 2017 was $-51m a 66.81% decrease of -34m from 2016
  • Arcus Biosciences Inc Annual EBITDA for 2016 was $-17m
Other Income Statement Metrics:
  • Arcus Biosciences Inc Net Income for the quarter ending December 12, 2018 was $-12m a -5.36% increase of 1m year over year
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS EBITDA Data

12/2018$-13m
09/2018$-11m
06/2018$-15m
03/2018$-13m
12/2017$-13m
09/2017$-22m
06/2017$-9m
03/2017$-7m

Annual RCUS EBITDA Data

2018$-51m
2017$-51m
2016$-17m